化学空间
药品
药物发现
计算生物学
计算机科学
纳米技术
化学
医学
生物
药理学
生物信息学
材料科学
作者
Alan Talevi,Lucas N. Alberca,Carolina L. Bellera
标识
DOI:10.1080/17460441.2025.2555275
摘要
Modern deep learning architectures have been adapted for the de novo design and molecular optimization. These technologies, and especially those based on conditional generation, will possibly have a great impact on expanding the regions of chemical space that are exploited therapeutically. However, there are some persistent challenges in the field that are gradually being addressed, including how to assess the synthetic accessibility of designed molecules without compromising the generation of structural novelty; the need to increase the availability and diversity of benchmark datasets; and the relative scarcity of large-scale experimental validation of the designs.
科研通智能强力驱动
Strongly Powered by AbleSci AI